The impact of selectins on mortality in stable carotid atherosclerosis

Matthias Hoke, Max-Paul Winter, Oswald Wagner

  • 1Georg Goliasch, MD, PhD, Division of Cardiology, Department of Internal Medicine II, Medical University Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria, Tel.: +43 1 40400 46140, Fax: +43 1 40400 42160,

Insights

Plasma levels of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) predict mortality in patients with carotid atherosclerosis. These selectins indicate endothelial activation and aid in risk stratification for cardiovascular events.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Biomarkers

Background:

  • Cellular adhesion molecules, specifically selectins, facilitate inflammatory cell recruitment to the arterial wall, contributing to atherosclerotic plaque formation.
  • Intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and endothelial-leukocyte adhesion molecule 1 (ELAM-1/E-selectin) mediate leukocyte attachment and are implicated in atherosclerotic plaque destabilization.

Purpose of the Study:

  • To investigate the association between plasma selectin levels and adverse clinical outcomes in patients with carotid atherosclerosis.
  • To determine if ICAM-1, VCAM-1, and E-selectin can serve as predictors of cardiovascular and all-cause mortality.

Main Methods:

  • Prospective study of 855 patients with sonographically confirmed carotid atherosclerosis.
  • Median follow-up of 6.2 years, with monitoring for all-cause and cardiovascular mortality.
  • Statistical analysis using adjusted hazard ratios (HR) and confidence intervals (CI) to assess the association between selectin levels and mortality.

Main Results:

  • Elevated plasma levels of ICAM-1 and VCAM-1 were significantly associated with increased cardiovascular mortality (HR: 3.43 and 2.51, respectively) and all-cause mortality when comparing the highest to lowest quartiles.
  • No significant association was found between E-selectin levels and all-cause or cardiovascular mortality.
  • ICAM-1 and VCAM-1 were identified as strong, independent predictors of mortality in this patient cohort.

Conclusions:

  • Plasma ICAM-1 and VCAM-1 levels are significant predictors of all-cause and cardiovascular mortality in patients with stable carotid atherosclerosis.
  • These selectins, elevated during endothelial activation, may serve as valuable biomarkers for monitoring anti-atherosclerotic therapy and identifying high-risk individuals.
  • Further research could explore their utility in guiding therapeutic strategies for carotid atherosclerosis management.

Related Concept Videos

Selectins01:25

Selectins

Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
4.8K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
602
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.1K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K